Literature DB >> 26253696

Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD).

Valérie Vilmont1, Odile Filhol2, Anne-Marie Hesse3, Yohann Couté3, Christophe Hue4, Léa Rémy-Tourneur5, Sylvie Mistou5, Claude Cochet6, Gilles Chiocchia7.   

Abstract

The Fas associated death domain protein (FADD) is the key adaptor molecule of the apoptotic signal triggered by death receptors of the TNF-R1 superfamily. Besides its crucial role in the apoptotic machinery, FADD has proved to be important in many biological processes like tumorigenesis, embryonic development or cell cycle progression. In a process to decipher the regulatory mechanisms underlying FADD regulation, we identified the anti-apoptotic kinase, CK2, as a new partner and regulator of FADD sub-cellular localization. The blockade of CK2 activity induced FADD re-localization within the cell. Moreover, cytoplasmic FADD was increased when CK2β was knocked down. In vitro kinase and pull down assays confirmed that FADD could be phosphorylated by the CK2 holoenzyme. We found that phosphorylation is weak with CK2α alone and optimal in the presence of stoichiometric amounts of CK2α catalytic and CK2β regulatory subunit, showing that FADD phosphorylation is undertaken by the CK2 holoenzyme in a CK2β-driven fashion. We found that CK2 can phosphorylate FADD on the serine 200 and that this phosphorylation is important for nuclear localization of FADD. Altogether, our results show for the first time that multifaceted kinase, CK2, phosphorylates FADD and is involved in its sub-cellular localization. This work uncovered an important role of CK2 in stable FADD nuclear localization.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CK2; FADD; Nuclear localization; Phosphorylation; Regulation

Mesh:

Substances:

Year:  2015        PMID: 26253696     DOI: 10.1016/j.bbamcr.2015.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

2.  MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.

Authors:  Meng Zhu; Ning Zhang; Shuixiang He; Ruirui Yan; Jun Zhang
Journal:  Clin Exp Metastasis       Date:  2016-05-03       Impact factor: 5.150

3.  Demonstration of subcellular migration of CK2α localization from nucleus to sarco(endo)plasmic reticulum in mammalian cardiomyocytes under hyperglycemia.

Authors:  Ceylan Verda Bitirim; Erkan Tuncay; Belma Turan
Journal:  Mol Cell Biochem       Date:  2017-10-20       Impact factor: 3.396

4.  The size-speed-force relationship governs migratory cell response to tumorigenic factors.

Authors:  Aldo Leal-Egaña; Gaelle Letort; Jean-Louis Martiel; Andreas Christ; Timothée Vignaud; Caroline Roelants; Odile Filhol; Manuel Théry
Journal:  Mol Biol Cell       Date:  2017-04-20       Impact factor: 4.138

5.  Beclin-1-mediated Autophagy Protects Against Cadmium-activated Apoptosis via the Fas/FasL Pathway in Primary Rat Proximal Tubular Cell Culture.

Authors:  Gang Liu; Yan Yuan; Mengfei Long; Tongwang Luo; Jianchun Bian; Xuezhong Liu; Jianhong Gu; Hui Zou; Ruilong Song; Yi Wang; Lin Wang; Zongping Liu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

6.  Capsular Polysaccharide of Mycoplasma ovipneumoniae Induces Sheep Airway Epithelial Cell Apoptosis via ROS-Dependent JNK/P38 MAPK Pathways.

Authors:  Zhongjia Jiang; Fuyang Song; Yanan Li; Di Xue; Ning Zhao; Jiamei Zhang; Guangcun Deng; Min Li; Xiaoming Liu; Yujiong Wang
Journal:  Oxid Med Cell Longev       Date:  2017-03-07       Impact factor: 6.543

7.  Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization.

Authors:  Maria F Gottardo; Carla S Capobianco; Johanna E Sidabra; Juan Garona; Yasser Perera; Silvio E Perea; Daniel F Alonso; Hernan G Farina
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

Review 8.  FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications.

Authors:  José L Marín-Rubio; Laura Vela-Martín; José Fernández-Piqueras; María Villa-Morales
Journal:  Cancers (Basel)       Date:  2019-09-29       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.